Oral Drug S-1 Linked to Longer Survival Than Capecitabine in Metastatic Breast Cancer Study
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...
A new scoping review of 30 studies synthesizes the emerging evidence on time toxicity in cancer care, showing how treatment ...
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
A new commentary in Supportive Care in Cancer urges researchers to distinguish between mono-construct and multi-construct uses of latent profile ...
A large Brazilian study of 527 palliative care patients found that older age and reduced Karnofsky performance status independently predict ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
Researchers propose the Lethal Isotherm Ratio, a standardized metric showing how much of a visible cryoablation ice ball is actually ...
A new systematic review and meta-analysis of 21 studies finds that virtual reality interventions significantly reduce anxiety in cancer patients ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine